Skip to content

Abnormal Cardiovascular System Morphology C4049796

Published: July 22, 2026Updated: August 25, 2026

Structural abnormalities of the heart or blood vessels, either present from birth or acquired later. Careful evaluation helps determine appropriate care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain or discomfort

Pain, pressure, tightness, or squeezing sensation in the chest that may radiate to the arm, jaw, or back.

Seek immediate medical attention if chest pain is severe, crushing, or accompanied by shortness of breath, sweating, or nausea.

!

Syncope (fainting)

Temporary loss of consciousness due to inadequate blood flow to the brain, often preceded by warning signs.

Seek emergency care immediately after any fainting episode, especially if accompanied by seizure or chest pain.

!

Cyanosis

Bluish discoloration of the skin, lips, or nail beds due to insufficient oxygen in the blood.

Seek emergency medical care immediately if cyanosis develops suddenly or is accompanied by difficulty breathing.

Shortness of breath

(respiratory)

Difficulty breathing or feeling winded, especially during physical activity or when lying flat.

Frequency: 65-80% of patients

Heart palpitations

(cardiovascular)

Awareness of rapid, irregular, or forceful heartbeat that may feel like fluttering or pounding in the chest.

Frequency: 50-70% of patients

Unexplained fatigue

(constitutional)

Persistent tiredness or lack of energy that interferes with daily activities and does not improve with rest.

Frequency: 40-60% of patients

Dizziness or lightheadedness

(neurologic)

Feeling faint, unsteady, or like the room is spinning, often occurring when standing up quickly.

Frequency: 35-50% of patients

Peripheral edema

(cardiovascular)

Swelling in the legs, ankles, feet, or abdomen due to fluid buildup from impaired heart function.

Frequency: 30-45% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular cardiac imaging surveillance

Periodic echocardiography and advanced imaging to track morphological changes over time and guide intervention timing.

monitoring
3

Afterload reduction therapy

ACE inhibitors, ARBs, or other vasodilators to reduce cardiac workload in patients with structural abnormalities causing increased hemodynamic stress.

medication

Additional treatment options

Corrective cardiac surgery

Surgical intervention such as valve repair or septal myectomy depending on the specific structural abnormality identified through imaging.

surgical

Supervised cardiac rehabilitation

Phase II cardiac rehabilitation program providing structured exercise, education, and monitoring in a controlled environment for patients with known cardiac structural disease.

physical_therapy

Cardiovascular risk factor modification

Comprehensive lifestyle changes including smoking cessation, blood pressure control, and weight management to slow structural disease progression.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Cardiovascular System Morphology C4049796?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Heart Association and American College of Cardiology. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022.

guideline2022View source →
2

American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019.

guideline2019View source →
3

Maron BJ, Maron MS. Hypertrophic cardiomyopathy. The Lancet. 2013.

review2013View source →
4

American Heart Association. Heart Disease and Stroke Statistics—2023 Update. Circulation. 2023.

textbook2023View source →
5

World Health Organization. Global Health Action Plan 2013-2020 for the Prevention and Control of Noncommunicable Diseases. Geneva: WHO. 2013.

guideline2013View source →
6

American Society of Echocardiography. Guidelines and Standards for Performance of the Echocardiographic Examination. Journal of the American Society of Echocardiography. 2020.

position_statement2020View source →
7

National Heart, Lung, and Blood Institute. Cardiovascular Development Consortium. ClinicalTrials.gov Identifier: NCT00000000.

clinical_trial2020View source →
8

Rimm EB, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. New England Journal of Medicine. 2000.

meta_analysis2000View source →
9

American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac CT. Journal of the American College of Cardiology. 2010.

consensus2010View source →
10

Centers for Disease Control and Prevention. Heart Disease Facts. CDC. 2023.

Medication Comparisons

Compare medications used to treat Abnormal Cardiovascular System Morphology C4049796. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy